Skip to main content

Table 1 Characteristics of participants involved in the preference eliciting study

From: Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts

Characteristics

Pooled (n = 220)

Ethiopia (n = 100)

Switzerland (n = 120)

Sex

 Male, n(%)

111 (50.4)

54 (54.0)

57 (47.5)

 Female

109 (49.6)

46 (46.0)

63 (52.5)

Age

 Mean (SD)

52.9 (0.6)

49.7 (0.7)

55.6 (0.8)

 40–64

195 (88.6)

96 (96.0)

99 (82.5)

  ≥ 65–81

25 (11.4)

4 (4.0)

21 (17.5)

Education

 Mean in years (SD)

10.12 (0.4)

6.55 (0.6)

13.1 (0.4)

 None

25 (11.4)

25 (25.0)

0

 Primary

46 (20.9)

42 (42.0)

4 (3.3)

 Secondary

70 (31.8)

16 (16.0)

54 (45.0)

 Higher

79 (35.9)

17 (17.0)

62 (51.7)

Job

 Salaried

107 (48.2)

35 (35.0)

71 (59.2)

 Own business

46 (20.9)

24 (24.0)

22 (18.3)

 Pensioned

28 (12.7)

4 (4.0)

24 (20.0)

 No job

39 (18.2)

37 (37.0)

3 (2.5)

 Current or previous statin users

20 (9.1)

8(8.0)

12(10.0)

Co-living person

 Alone

48 (21.8)

11 (11.0)

37 (30.8)

 Family

171 (78.2)

89 (89.0)

83 (69.2)

Respondents understand the content and procedure of the questionnaire

 Strongly agree

83 (37.7)

7 (7.0)

76 (63.4)

 Agree

116 (52.7)

77 (77.0)

39 (32.5)

 Neither

20 (9.1)

16 (16.0)

4 (3.3)

 Disagree

1 (0.5)

0

1 (0.8)

Morbidity

 None

149 (67.7)

81 (81.0)

68 (56.7)

 Yes a

71 (32.3)

19 (19.0)

52 (43.3)

  1. aHypertension, type 2 diabetes, join/muscle disease, cancer, psychiatric disease were most frequently reported